enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Romosozumab - Wikipedia

   en.wikipedia.org/wiki/Romosozumab

   Romosozumab is used for osteoporosis to decrease the risk of fractures. [10] Two trials found that it reduced the rate of vertebral fracture. In one, there was a 73% lower risk of vertebral fracture after one year, and the benefit was maintained after a second year of taking denosumab.

3. US FDA adds 'boxed warning' for Amgen's bone loss drug Prolia

   www.aol.com/news/us-fda-adds-boxed-warning...

   Several other drugs, which treat bone loss or osteoporosis, including Merck's Fosamax, Amgen's Xgeva and Evenity, already come with safety information that warn against prescribing the drug to ...

4. Amgen's (AMGN) Osteoporosis Drug Evenity Gets FDA Approval - AOL

   www.aol.com/news/amgens-amgn-osteoporosis-drug...

   Amgen (AMGN) gets approval in the United States for osteoporosis drug, Evenity. Skip to main content. Sign in. Mail. 24/7 Help. For premium support please call: 800-290-4726 more ...

5. Amgen's Prolia Wins New Uses, Performs in Study

   www.aol.com/news/2011-09-20-amgens-prolia-wins...

   It's good news on top of good news for Amgen (NAS: AMGN) . The company's new bone drug is gathering indications -- and potential sales -- like a snowball rolling downhill. Under the name Prolia ...

6. Amgen - Wikipedia

   en.wikipedia.org/wiki/Amgen

   2010: On June 6, 2010, Amgen received FDA approval for Prolia, a protein drug for the treatment of post-menopausal osteoporosis. [45] In clinical trials, Prolia reduced the rate of vertebral fractures by 61% and the risk of hip fractures by 40%. [46]

7. Amgen's Osteoporosis Drug Evenity Gets Approval in Europe - AOL

   www.aol.com/news/amgens-osteoporosis-drug...

   The EC grants marketing authorization to Amgen (AMGN) and partner UCB's Evenity for the treatment of severe osteoporosis in postmenopausal women at high risk of fracture.

8. List of largest selling pharmaceutical products - Wikipedia

   en.wikipedia.org/wiki/List_of_largest_selling...

   Drug Trade name Type Main indications Company Sales (USD millions/year) ∆ vs 2014 1 Adalimumab: Humira Biologic Rheumatoid arthritis: AbbVie Inc. 14,012 1,469 2 Ledipasvir/sofosbuvir: Harvoni Small molecule Hepatitis C: Gilead Sciences: 13,864 11,737 3 Etanercept: Enbrel Biologic Rheumatoid arthritis: Amgen. Pfizer. 8,697 4,009 4 Infliximab ...

9. Amgen 'encouraged' by weight-loss drug interim data ... - AOL

   www.aol.com/news/amgen-first-quarter-profit-dips...

   Quarterly product sales were led by an 8% jump for osteoporosis drug Prolia to $999 million, and a 33% increase to $517 million for cholesterol drug Repatha. Sales of rheumatoid arthritis drug ...